论文部分内容阅读
在2001年6月的美国糖尿病学会第61届科学研讨会上，发布的Inhale Therapeutic、Aventis和Pfizer公司的吸入型胰岛素制剂Exubera的III期临床研究数据表明，本品有望为糖尿病患者胰岛素治疗带来一种新的给药途径。本品应用Inhale Therapeutic公司先进的吸入给药技术，将胰岛素干?
In the June 2001 symposium of the American Diabetes Association at the 61st Symposium, Phase III clinical data from Inhale Therapeutic, Aventis and Pfizer’s inhaled insulin formulation Exubera showed that this product is expected to bring insulin therapy to patients with diabetes A new route of administration. This product uses Inhale Therapeutic’s advanced inhalation drug delivery technology, the insulin dry?